Barclays’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $390K | Buy |
145,407
+44,373
| +44% | +$119K | ﹤0.01% | 3168 |
|
|
2025
Q1 | $142K | Sell |
101,034
-40,461
| -29% | -$56.9K | ﹤0.01% | 3535 |
|
|
2024
Q4 | $282K | Buy |
141,495
+13,756
| +11% | +$27.4K | ﹤0.01% | 3355 |
|
|
2024
Q3 | $402K | Buy |
127,739
+93,890
| +277% | +$295K | ﹤0.01% | 3110 |
|
|
2024
Q2 | $107K | Buy |
+33,849
| New | +$107K | ﹤0.01% | 3340 |
|
|
2023
Q3 | – | Sell |
-314,925
| Closed | -$677K | – | 4235 |
|
|
2023
Q2 | $677K | Sell |
314,925
-19,347
| -6% | -$41.6K | ﹤0.01% | 2409 |
|
|
2023
Q1 | $652K | Buy |
+334,272
| New | +$652K | ﹤0.01% | 2451 |
|